ELP1 and neoplasm: So far, given the limited number of publications reporting the phenotype and outcomes of ELP1 germline PV carriers, the actual penetrance and cancer spectrum of this emerging CPS remain uncertain, which precludes adapted recommendations for both testing asymptomatic relatives and tumor surveillance in PV carriers.